comprehensive -WSS

comprehensive

author：Wikipedia 2025-09-28 00:50:21 - browse：251

Pfizer and Moderna aren’t the only vaccine money-makers. Much of the revenue and profits from Covid-19 vaccines are flowing behind the scenes, going to the contract manufacturers and clinical-trial organizers that turn the shots from lab-bench theory to mass-produced reality.

Both AstraZeneca and Johnson & Johnson publicly committed to not profiting off their products during the pandemic — though AstraZeneca has reserved the right to declare the pandemic over on July 1, even if the World Health Organization has not. Pfizer and Moderna made no such pledge, with Pfizer expected to make $15 billion in vaccine-related revenue this year, while Moderna is forecasting $18.4 billion in vaccine sales.

Contractors hired to test and manufacture these vaccines have enjoyed a share of the profits without the same level of public scrutiny.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： What does generative AI mean for health care? We asked experts
Next article： Boston Scientific acquires urology company Axonics for $3.7 billion

WSS

Medicare Advantage overpayments discussion gets experts fired up

Does Paxlovid work in people vaccinated against Covid

Allen Institute goes after foundational questions, CEO Costa says

Fauci's latest grilling in Congress: 9 hours, behind closed doors

5 dead in mass shooting on Caribbean island of St. Vincent: Police

Merck to acquire Harpoon Therapeutics for $680 million

leisure time

comprehensive

entertainment

DIEP, the 'gold standard' of breast reconstruction, is under threat

JPM 2024: Biotech’s most prolific dealmaker sees a rosy 2024

State Dept. review finds Biden bears some blame for Afghanistan failures

Are infertility treatments 'essential' during the Covid

Malaria cases in Florida and Texas: Here’s what you need to know

Delta passengers in Vegas fall sick while waiting on flight in triple

Trump demands the U.S. pay no more for drugs than other countries … again

Allen Institute goes after foundational questions, CEO Costa says

Virginia high school admissions case could be legal follow

FDA panel unanimously endorses Eisai’s Alzheimer’s drug Leqembi

entertainment

JPM 2024 Review: Hope for the XBI, deals from J&J, Merck, GSK

The stock market has soared this year, but will it last? Experts weigh in

Mystery swirls around US soldier who entered North Korea days ago, officials say

Allen Institute goes after foundational questions, CEO Costa says

Stanford president’s abrupt resignation sparks debate

Scientists grapple with ethics of stem cell research

explore

focus

leisure time

focus